Search - tctmd.com

Displaying 401 - 420 of 457

Sort: Relevancy | Date

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

November 16, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Conference News

EES Compared Favorably with SES In Two Pivotal Trials

November 08, 2011

News Daily News

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

November 06, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

FFR Guides Therapy for Proximal LAD Lesions

Jason Kahn

October 26, 2011

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

DISCOVER-FLOW Published: Noninvasive FFR Shows High Diagnostic Accuracy

Leah Lawrence

October 24, 2011

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

Study Proposes New CK-MB Threshold for Periprocedural MI

Caitlin E. Cox

October 12, 2011

News Daily News

Meta-analysis: Coronary Collateral Flow Linked to Reduced CAD Mortality

L.A. McKeown

October 07, 2011

Advertisement

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

PRISM Individualized Informed Consent Improves PCI Choice, Experience

RAPID GENE: Validation of Point-of-Care Genetic Testing

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

EES Compared Favorably with SES In Two Pivotal Trials

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

FFR Guides Therapy for Proximal LAD Lesions

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

DISCOVER-FLOW Published: Noninvasive FFR Shows High Diagnostic Accuracy

Six Months Sufficient for Dual Antiplatelet Therapy

Study Proposes New CK-MB Threshold for Periprocedural MI

Meta-analysis: Coronary Collateral Flow Linked to Reduced CAD Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content